The Global Payments Inc. (GPN) Scheduled to Post Quarterly Earnings on Monday

The Global Payments Inc. (GPN) Scheduled to Post Quarterly Earnings on Monday

Global Payments Inc. (NYSE:GPN) will issue its Q217 quarterly earnings data on Monday, January 9th. Analysts expect the company to announce earnings of $0.84 per share and revenue of $803.55 million for the quarter. Global Payments (NYSE:GPN) last announced its quarterly earnings data on Wednesday, October 5th. The company reported $0.86 EPS for the quarter, beating the Zacks’ consensus estimate of $0.83 by $0.03. Global Payments had a return on equity of 22.33% and a net margin of 8.74%. The firm earned $939.50 million during the quarter. During the same…

The Vitamin Shoppe, Inc (VSI) Upgrade by The Zacks Investment Research

The Vitamin Shoppe, Inc (VSI) Upgrade by The Zacks Investment Research

Vitamin Shoppe, Inc (NYSE:VSI) was upgraded by Zacks Investment Research from a “sell” rating to a “buy” rating in a research note issued on Friday. The brokerage presently has a $27.00 target price on the stock. Zacks Investment Research’s price target would suggest a potential upside of 14.89% from the stock’s previous close. According to Zacks, “Vitamin Shoppe is a specialty retailer and direct marketer of nutritional products. It primarily sells vitamins, minerals, nutritional supplements, herbs, sports nutrition formulas, homeopathic remedies, green living products and health and beauty aids. Based…

The Versartis, Inc. (VSAR) Rating Increased to Buy by The Zacks Investment Research

The Versartis, Inc. (VSAR) Rating Increased to Buy by The Zacks Investment Research

Versartis, Inc. (NASDAQ:VSAR) was upgraded by Zacks Investment Research from a “hold” rating to a “buy” rating in a report released on Friday. The firm currently has a $17.00 price objective on the biopharmaceutical company’s stock. Zacks Investment Research’s price objective indicates a potential upside of 7.26% from the company’s previous close. According to Zacks, “Versartis, Inc. operates as a biotechnology company. It develops therapeutic proteins for the treatment of metabolic diseases and endocrine disorders. The Company is developing VRS-317, a long-acting recombinant human growth hormone, which is in Phase…

The Vectrus, Inc. (VEC) Upgraded to “Strong-Buy” by The Zacks Investment Research

The Vectrus, Inc. (VEC) Upgraded to “Strong-Buy” by The Zacks Investment Research

Vectrus, Inc. (NYSE:VEC) was upgraded by Zacks Investment Research from a “hold” rating to a “strong-buy” rating in a report issued on Friday. The firm presently has a $27.00 price target on the stock. Zacks Investment Research’s target price would suggest a potential upside of 13.26% from the company’s previous close. According to Zacks, “Vectrus, Inc. engages in providing infrastructure asset management, logistics and supply chain management, and information technology and network communication services. Its services include operations, maintenance, management, engineering and sustainment for physical assets including a wide variety…

The Virtus Investment Partners, Inc. (VRTS) Decreased to Sell by The Zacks Investment Research

The Virtus Investment Partners, Inc. (VRTS) Decreased to Sell by The Zacks Investment Research

Virtus Investment Partners, Inc. (NASDAQ:VRTS) was downgraded by Zacks Investment Research from a “hold” rating to a “sell” rating in a research note issued on Friday. According to Zacks, “Virtus Investment Partners, Inc., headquartered in Hartford, Connecticut, provides investment management products and services to individuals and institutions in the United States. . It operates a multi-manager asset management business, comprising a number of individual affiliated managers, each with a distinct investment style, autonomous investment process and individual brand. Investors have an array of needs and Virtus Investment Partners offers a…

The Abercrombie & Fitch Company (ANF) Given a $12.00 Price Target by the RBC Capital Markets Analysts

The Abercrombie & Fitch Company (ANF) Given a $12.00 Price Target by the RBC Capital Markets Analysts

RBC Capital Markets set a $12.00 price target on Abercrombie & Fitch Company (NYSE:ANF) in a research note issued to investors on Thursday morning. The brokerage currently has a sell rating on the apparel retailer’s stock. Several other equities research analysts have also recently issued reports on ANF. Vetr cut Abercrombie & Fitch Company from a strong-buy rating to a buy rating and set a $15.36 price target for the company. in a research note on Tuesday, November 1st. Stifel Nicolaus reiterated a hold rating on shares of Abercrombie &…

The Holowesko Partners Ltd. Increases Stake in Baidu, Inc. (BIDU)

The Holowesko Partners Ltd. Increases Stake in Baidu, Inc. (BIDU)

Holowesko Partners Ltd. boosted its position in shares of Baidu, Inc. (NASDAQ:BIDU) by 6.3% during the third quarter, Holdings Channel reports. The institutional investor owned 279,800 shares of the company’s stock after buying an additional 16,500 shares during the period. Baidu accounts for 4.6% of Holowesko Partners Ltd.’s holdings, making the stock its 11th largest position. Holowesko Partners Ltd.’s holdings in Baidu were worth $50,943,000 at the end of the most recent reporting period. A number of other hedge funds have also recently added to or reduced their stakes in…

The Hortonworks, Inc. (HDP) Insider Scott Reasoner Sold 1,750 Shares

The Hortonworks, Inc. (HDP) Insider Scott Reasoner Sold 1,750 Shares

Hortonworks, Inc. (NASDAQ:HDP) insider Scott Reasoner sold 1,750 shares of the company’s stock in a transaction on Tuesday, January 3rd. The shares were sold at an average price of $8.42, for a total transaction of $14,735.00. Following the transaction, the insider now owns 163,841 shares of the company’s stock, valued at $1,379,541.22. The transaction was disclosed in a filing with the SEC, which is available through this hyperlink. Scott Reasoner also recently made the following trade(s): Hortonworks, Inc. (NASDAQ:HDP) traded up 0.55% during midday trading on Friday, reaching $9.08. 19,881…

The Analysts Anticipate Anika Therapeutics Inc. (ANIK) to Post $0.52 EPS

The Analysts Anticipate Anika Therapeutics Inc. (ANIK) to Post $0.52 EPS

Anika Therapeutics Inc. (NASDAQ:ANIK) has received an average broker rating score of 1.00 (Strong Buy) from the two analysts that provide coverage for the stock, Zacks Investment Research reports. Two equities research analysts have rated the stock with a strong buy recommendation. Brokerages have set a one year consensus target price of $59.00 for the company and are predicting that the company will post $0.52 EPS for the current quarter, according to Zacks. Zacks has also given Anika Therapeutics an industry rank of 64 out of 265 based on the…

The First Mid-Illinois Bancshares, Inc. (FMBH) Receives Average Recommendation of “Strong Buy” from the Analysts

The First Mid-Illinois Bancshares, Inc. (FMBH) Receives Average Recommendation of “Strong Buy” from the Analysts

Shares of First Mid-Illinois Bancshares, Inc. (NASDAQ:FMBH) have been assigned a consensus broker rating score of 1.00 (Strong Buy) from the one analysts that provide coverage for the stock, Zacks Investment Research reports. One investment analyst has rated the stock with a strong buy recommendation. Analysts have set a one year consensus price target of $29.00 for the company and are expecting that the company will post $0.51 earnings per share for the current quarter, according to Zacks. Zacks has also assigned First Mid-Illinois Bancshares an industry rank of 46…

The Compass Diversified Holdings (CODI) Insider James Bottiglieri Buys 4,500 Shares of Stock

The Compass Diversified Holdings (CODI) Insider James Bottiglieri Buys 4,500 Shares of Stock

Compass Diversified Holdings (NYSE:CODI) insider James Bottiglieri bought 4,500 shares of the company’s stock in a transaction on Tuesday, January 3rd. The shares were purchased at an average cost of $18.16 per share, for a total transaction of $81,720.00. Following the transaction, the insider now owns 42,462 shares in the company, valued at $771,109.92. The purchase was disclosed in a filing with the Securities & Exchange Commission, which is available through the SEC website. Compass Diversified Holdings (NYSE:CODI) traded up 0.417% on Friday, reaching $18.075. 109,624 shares of the company…

The W.R. Grace & Co. (GRA) Coverage Initiated by the Analysts at the Aegis

The W.R. Grace & Co. (GRA) Coverage Initiated by the Analysts at the Aegis

Aegis started coverage on shares of W.R. Grace & Co. (NYSE:GRA) in a research report report published on Thursday morning. The brokerage issued a buy rating on the stock. Several other research firms have also weighed in on GRA. Jefferies Group reiterated a buy rating and issued a $80.00 price objective (down previously from $89.00) on shares of W.R. Grace & Co. in a research note on Thursday, October 27th. Credit Suisse Group set a $82.00 price target on shares of W.R. Grace & Co. and gave the stock a…

The Welltower Inc. (HCN) Stake Reduced by the Great West Life Assurance Co. Can

The Welltower Inc. (HCN) Stake Reduced by the Great West Life Assurance Co. Can

Great West Life Assurance Co. Can reduced its stake in shares of Welltower Inc. (NYSE:HCN) by 3.1% during the third quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm owned 517,728 shares of the real estate investment trust’s stock after selling 16,449 shares during the period. Great West Life Assurance Co. Can’s holdings in Welltower were worth $38,680,000 at the end of the most recent reporting period. Other large investors have also bought and sold shares of the company. Hartford Financial Management…

The Great West Life Assurance Co. Can Decreases Position in Norfolk Souther Corporation (NSC)

The Great West Life Assurance Co. Can Decreases Position in Norfolk Souther Corporation (NSC)

Great West Life Assurance Co. Can reduced its stake in Norfolk Souther Corporation (NYSE:NSC) by 6.9% during the third quarter, Holdings Channel reports. The institutional investor owned 402,557 shares of the railroad operator’s stock after selling 29,703 shares during the period. Great West Life Assurance Co. Can’s holdings in Norfolk Souther Corporation were worth $39,078,000 at the end of the most recent quarter. A number of other hedge funds and other institutional investors also recently added to or reduced their stakes in the company. Alpha Omega Wealth Management LLC increased…

The Shaftesbury plc’s (SHB) “Hold” Rating Reaffirm at the Liberum Capital

The Shaftesbury plc’s (SHB) “Hold” Rating Reaffirm at the Liberum Capital

Liberum Capital reaffirmed their hold rating on shares of Shaftesbury plc (LON:SHB) in a research report report published on Thursday. Liberum Capital currently has a GBX 1,000 ($12.29) price target on the real estate investment trust’s stock. Several other research analysts also recently issued reports on the company. BNP Paribas reaffirmed an underperform rating and set a GBX 850 ($10.45) price target on shares of Shaftesbury plc in a research note on Tuesday, October 11th. Numis Securities Ltd cut their price target on Shaftesbury plc from GBX 897 ($11.02) to…

The Express Scripts Holding Company (ESRX) Shares Sold by the Great West Life Assurance Co. Can

The Express Scripts Holding Company (ESRX) Shares Sold by the Great West Life Assurance Co. Can

Great West Life Assurance Co. Can reduced its position in Express Scripts Holding Company (NASDAQ:ESRX) by 20.5% during the third quarter, according to its most recent filing with the Securities and Exchange Commission. The institutional investor owned 701,165 shares of the company’s stock after selling 180,834 shares during the period. Great West Life Assurance Co. Can’s holdings in Express Scripts Holding Company were worth $49,412,000 at the end of the most recent quarter. Several other hedge funds and other institutional investors have also recently modified their holdings of ESRX. Baskin…

The Ultra Electronics Holdings plc (ULE) Price Target Increased to GBX 2,260 by the Analysts at the J P Morgan Chase & Co

The Ultra Electronics Holdings plc (ULE) Price Target Increased to GBX 2,260 by the Analysts at the J P Morgan Chase & Co

Ultra Electronics Holdings plc (LON:ULE) had its price objective increased by J P Morgan Chase & Co from GBX 2,175 ($26.73) to GBX 2,260 ($27.77) in a research report report published on Thursday. J P Morgan Chase & Co currently has an overweight rating on the stock. A number of other research firms also recently issued reports on ULE. Goldman Sachs Group, Inc. (The) restated a neutral rating and set a GBX 1,933 ($23.76) price target on shares of Ultra Electronics Holdings plc in a research note on Thursday, December…

The Lithia Motors, Inc. (LAD) Receives Consensus Recommendation of “Buy” from the Analysts

The Lithia Motors, Inc. (LAD) Receives Consensus Recommendation of “Buy” from the Analysts

Shares of Lithia Motors, Inc. (NYSE:LAD) have been given a consensus recommendation of “Buy” by the six research firms that are presently covering the company. One analyst has rated the stock with a sell rating and five have issued a buy rating on the company. The average 1-year price objective among analysts that have covered the stock in the last year is $109.67. LAD has been the topic of several recent analyst reports. Zacks Investment Research raised Lithia Motors from a “hold” rating to a “buy” rating and set a…

The Randgold Resources Limited (GOLD) Receives Average Rating of “Buy” from the Analysts

The Randgold Resources Limited (GOLD) Receives Average Rating of “Buy” from the Analysts

Shares of Randgold Resources Limited (NASDAQ:GOLD) have received an average recommendation of “Buy” from the nineteen analysts that are currently covering the stock. One equities research analyst has rated the stock with a sell recommendation, five have issued a hold recommendation and thirteen have given a buy recommendation to the company. GOLD has been the topic of several analyst reports. Zacks Investment Research raised Randgold Resources Limited from a “hold” rating to a “buy” rating and set a $101.00 target price on the stock in a research report on Wednesday,…

The Great West Life Assurance Co. Can Increases Position in Aetna Inc. (AET)

The Great West Life Assurance Co. Can Increases Position in Aetna Inc. (AET)

Great West Life Assurance Co. Can raised its stake in shares of Aetna Inc. (NYSE:AET) by 3.4% during the third quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm owned 360,087 shares of the company’s stock after buying an additional 11,961 shares during the period. Great West Life Assurance Co. Can’s holdings in Aetna were worth $41,573,000 at the end of the most recent reporting period. A number of other large investors have also bought and sold shares of the stock….